The ASK1 dependent activation of p38 and JNK MAPK pathways finally triggered the apoptotic death of AML cells, as evident from a dose-dependent elevation of apoptotic markers such as cleaved PARP and caspase 3 (Fig. 10E). The gene discussed is CASP3; the disease is acute myeloid leukemia.